Cipla, Lupin Emphatically Deny Reports Of Merger Talks With Takeda
This article was originally published in PharmAsia News
Executive Summary
Cipla and Lupin denied they were holding merger talks with Takeda Pharmaceutical, as reported by an Indian newspaper, which cited sources